Global Neuromodulation Devices Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 10/11/2022
- NO OF PAGES
- 206
- CATEGORY
- Healthcare & Life Sciences
In 2021, the market for Neuromodulation Devices worldwide was worth $4.5 billion US dollars. AMR Group projects that the market will reach US$ 8.9 billion by 2031, growing at a CAGR of 10.2 percent between 2022 and 2031.
Industry Overview
Neuromodulation devices are medical devices that are used to treat various neurological disorders by delivering electrical or chemical signals to specific areas of the nervous system. These devices work by altering the electrical activity of nerve cells, which can help to alleviate pain, improve motor function, and reduce the symptoms of various neurological disorders. There are several different types of neuromodulation devices, including: Spinal cord stimulators: These devices are implanted under the skin and use electrical signals to block pain signals from reaching the brain. They are used to treat chronic pain conditions, such as back pain and neuropathic pain. Deep brain stimulators: These devices are implanted in the brain and use electrical signals to treat movement disorders, such as Parkinson's disease and essential tremor. Vagus nerve stimulators: These devices are implanted in the neck and use electrical signals to treat epilepsy and depression. Sacral nerve stimulators: These devices are implanted in the lower back and use electrical signals to treat urinary and fecal incontinence. Transcranial magnetic stimulation devices: These devices use magnetic fields to stimulate specific areas of the brain and are used to treat depression. Neuromodulation devices are becoming increasingly important in the field of neurology, as they offer a non-invasive and effective way to treat various neurological disorders. They are also being used in research to better understand the functioning of the nervous system and to develop new treatments for neurological disorders.
Market Dynamics
The neuromodulation devices market is driven by several factors, including: Increasing prevalence of neurological disorders: The rising incidence of neurological disorders, such as chronic pain, epilepsy, Parkinson's disease, and depression, is a major driver of the neuromodulation devices market. As the aging population grows and the prevalence of chronic diseases increases, the demand for neuromodulation devices is expected to rise. Advancements in technology: Advances in neuromodulation technology, such as high-frequency spinal cord stimulation and closed-loop deep brain stimulation, are driving the growth of the market. Newer devices are more effective, less invasive, and more targeted, making them more appealing to patients and healthcare providers. Favorable reimbursement policies: The availability of favorable reimbursement policies for neuromodulation devices is driving the growth of the market. In many countries, these devices are covered by government and private insurance plans, making them more accessible to patients.
Growing awareness and acceptance: As awareness of the benefits of neuromodulation devices grows, more patients are opting for these devices as a treatment option. Additionally, as more research is conducted on the safety and efficacy of these devices, their acceptance among healthcare providers is also increasing. However, there are also some challenges facing the neuromodulation devices market, including: High cost of devices: The high cost of neuromodulation devices is a major barrier to their adoption, particularly in developing countries. The cost of implantation, maintenance, and replacement can also be significant, limiting the affordability of these devices for some patients.
Regulatory challenges: The regulatory environment for neuromodulation devices can be complex, with different countries and regions having different regulations and approval processes. This can make it difficult for manufacturers to bring their devices to market. Side effects and complications: Neuromodulation devices can cause side effects and complications, such as infection, device malfunction, and nerve damage. These risks can limit their adoption and use in some patient populations. Despite these challenges, the neuromodulation devices market is expected to continue to grow, driven by the increasing prevalence of neurological disorders and the development of new and more advanced devices.
COVID Impact
The COVID-19 pandemic has had both positive and negative impacts on the neuromodulation devices market. On the positive side, the pandemic has increased the demand for neuromodulation devices as patients seek non-invasive treatments that do not require hospitalization. In addition, the pandemic has led to a significant increase in the use of telemedicine and remote patient monitoring, which has made it easier for patients to receive treatment with neuromodulation devices from the comfort of their own homes. On the negative side, the pandemic has also had some negative impacts on the neuromodulation devices market. The disruption of supply chains and manufacturing processes has led to delays and shortages in the production and delivery of neuromodulation devices. In addition, the reduction in elective surgeries and procedures during the pandemic has resulted in a decline in the number of implantations of neuromodulation devices. Overall, the impact of the COVID-19 pandemic on the neuromodulation devices market has been mixed. While there have been some challenges and disruptions, the increasing demand for non-invasive treatments and the growth of telemedicine are expected to drive the continued growth of the market in the post-pandemic era.
Regional Trend
The neuromodulation devices market varies by region due to differences in healthcare infrastructure, prevalence of neurological disorders, and regulatory environment. North America: North America is the largest market for neuromodulation devices, with the United States accounting for the majority of the market share. The region's market growth is driven by factors such as the high prevalence of neurological disorders, favorable reimbursement policies, and increasing investment in research and development.
Europe: Europe is the second-largest market for neuromodulation devices, with countries such as Germany, the UK, and France being the major contributors. The market growth is driven by factors such as the aging population, increasing prevalence of chronic pain and neurological disorders, and the presence of well-established healthcare infrastructure.
Asia-Pacific: The Asia-Pacific region is expected to see the fastest growth in the neuromodulation devices market due to the increasing prevalence of neurological disorders, increasing healthcare expenditure, and growing awareness of neuromodulation treatments. China, Japan, and India are the major contributors to the market in the region.
Latin America: The neuromodulation devices market in Latin America is expected to grow steadily due to factors such as increasing healthcare expenditure and the growing prevalence of neurological disorders. Brazil and Mexico are the major contributors to the market in the region.
Middle East and Africa: The neuromodulation devices market in the Middle East and Africa is expected to grow slowly due to factors such as the limited availability of neuromodulation devices, low healthcare expenditure, and limited awareness and acceptance of these devices among healthcare providers and patients. Overall, the neuromodulation devices market is expected to grow globally due to the increasing prevalence of neurological disorders and the development of new and more advanced devices. However, the growth rate and market size vary by region due to differences in healthcare infrastructure, prevalence of neurological disorders, and regulatory environment.
Competitive Landscape
The neuromodulation devices market is highly competitive with several players operating in the market. Some of the major companies in the market include:
Medtronic: Medtronic is a leading player in the neuromodulation devices market with a wide range of products, including spinal cord stimulators, deep brain stimulators, and sacral nerve stimulators.
Abbott: Abbott is a major player in the neuromodulation devices market, with a focus on neurostimulation devices for chronic pain management, including spinal cord stimulators and dorsal root ganglion stimulators.
Boston Scientific: Boston Scientific is a leading player in the neuromodulation devices market, with a range of products, including spinal cord stimulators, deep brain stimulators, and peripheral nerve stimulators.
LivaNova: LivaNova is a major player in the neuromodulation devices market, with a focus on vagus nerve stimulation for the treatment of epilepsy and depression.
Nevro: Nevro is a fast-growing player in the neuromodulation devices market, with a focus on high-frequency spinal cord stimulation for the treatment of chronic pain.
Other players in the market include Stimwave, Synapse Biomedical, NeuroMetrix, Nuvectra, and ElectroCore. The competitive landscape of the neuromodulation devices market is driven by factors such as product innovation, pricing strategies, regulatory approvals, and marketing and distribution strategies. With the increasing demand for neuromodulation devices, competition among the players is expected to intensify in the coming years.
Market Segmentation
The neuromodulation devices market can be segmented based on the type of device, application, and end-user:
By Type of Device:
Implantable Devices: This segment includes spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, and vagus nerve stimulators, among others.
External Devices: This segment includes transcranial magnetic stimulators, transcranial direct current stimulators, and transcutaneous electrical nerve stimulators, among others.
By Application:
Chronic Pain: This segment includes neuropathic pain, failed back surgery syndrome, complex regional pain syndrome, and chronic migraine, among others.
Movement Disorders: This segment includes Parkinson's disease, essential tremors, and dystonia, among others.
Epilepsy: This segment includes focal and generalized epilepsy.
Others: This segment includes urinary and fecal incontinence, gastroparesis, and depression, among others.
By End-User:
Hospitals: Hospitals are the major end-users of neuromodulation devices, where these devices are used for the treatment of chronic pain and neurological disorders.
Ambulatory Surgical Centers: Ambulatory surgical centers are gaining popularity as they provide same-day surgical services, including neuromodulation procedures, with shorter recovery time and lower cost.
Specialty Clinics: Specialty clinics provide specific medical services and treatments, including neuromodulation therapies, and are gaining popularity due to their specialized approach. The segmentation of the neuromodulation devices market helps in understanding the market demand for different types of devices, applications, and end-users. This information can be used by manufacturers to develop and market products that cater to specific market needs.
Global Neuromodulation Devices Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Neuromodulation Devices Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of Neuromodulation Devices
1.3 Neuromodulation Devices Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of Neuromodulation Devices
1.4.2 Applications of Neuromodulation Devices
1.5 Market Exchange Rate
2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source
3 Market Competition Analysis
3.1 BioControl Medical Market Performance Analysis
3.1.1 BioControl Medical Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 BioControl Medical Sales, Value, Price, Gross Margin 2016-2021
3.2 Neuropace Market Performance Analysis
3.2.1 Neuropace Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Neuropace Sales, Value, Price, Gross Margin 2016-2021
3.3 Medtronic Market Performance Analysis
3.3.1 Medtronic Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Medtronic Sales, Value, Price, Gross Margin 2016-2021
3.4 Synapse Biomedical Market Performance Analysis
3.4.1 Synapse Biomedical Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Synapse Biomedical Sales, Value, Price, Gross Margin 2016-2021
3.5 Cyberonics Market Performance Analysis
3.5.1 Cyberonics Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 Cyberonics Sales, Value, Price, Gross Margin 2016-2021
3.6 St.Jude Medical Market Performance Analysis
3.6.1 St.Jude Medical Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 St.Jude Medical Sales, Value, Price, Gross Margin 2016-2021
3.7 Neurosigma Market Performance Analysis
3.7.1 Neurosigma Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 Neurosigma Sales, Value, Price, Gross Margin 2016-2021
3.8 Neuronetics Market Performance Analysis
3.8.1 Neuronetics Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Neuronetics Sales, Value, Price, Gross Margin 2016-2021
3.9 Boston Scientific Corporation Market Performance Analysis
3.9.1 Boston Scientific Corporation Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Boston Scientific Corporation Sales, Value, Price, Gross Margin 2016-2021
3.10 Nevro Market Performance Analysis
3.10.1 Nevro Basic Information
3.10.2 Product and Service Analysis
3.10.3 Strategies for Company to Deal with the Impact of COVID-19
3.10.4 Nevro Sales, Value, Price, Gross Margin 2016-2021
4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global Neuromodulation Devices Production and Value by Type
4.1.1 Global Neuromodulation Devices Production by Type 2016-2021
4.1.2 Global Neuromodulation Devices Market Value by Type 2016-2021
4.2 Global Neuromodulation Devices Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 Deep Brain Stimulation (DBS) Systems Market Production, Value and Growth Rate
4.2.2 Spinal Cord Stimulator (SCS) Systems Market Production, Value and Growth Rate
4.2.3 Diaphragm Pacing System (DPS) Market Production, Value and Growth Rate
4.2.4 Respiratory Electrical Stimulation (RES) Market Production, Value and Growth Rate
4.2.5 Vagus Nerve Stimulation (VNS) Market Production, Value and Growth Rate
4.2.6 Gastric Electrical Stimulation (GES) Market Production, Value and Growth Rate
4.2.7 Transcranial Magnetic Stimulation (TMS) Market Production, Value and Growth Rate
4.2.8 Transcutaneous Electrical Nerve Stimulation (TENS) Market Production, Value and Growth Rate
4.3 Global Neuromodulation Devices Production and Value Forecast by Type
4.3.1 Global Neuromodulation Devices Production Forecast by Type 2022-2030
4.3.2 Global Neuromodulation Devices Market Value Forecast by Type 2022-2030
4.4 Global Neuromodulation Devices Market Production, Value and Growth Rate by Type Forecast 2022-2030
4.4.1 Deep Brain Stimulation (DBS) Systems Market Production, Value and Growth Rate Forecast
4.4.2 Spinal Cord Stimulator (SCS) Systems Market Production, Value and Growth Rate Forecast
4.4.3 Diaphragm Pacing System (DPS) Market Production, Value and Growth Rate Forecast
4.4.4 Respiratory Electrical Stimulation (RES) Market Production, Value and Growth Rate Forecast
4.4.5 Vagus Nerve Stimulation (VNS) Market Production, Value and Growth Rate Forecast
4.4.6 Gastric Electrical Stimulation (GES) Market Production, Value and Growth Rate Forecast
4.4.7 Transcranial Magnetic Stimulation (TMS) Market Production, Value and Growth Rate Forecast
4.4.8 Transcutaneous Electrical Nerve Stimulation (TENS) Market Production, Value and Growth Rate Forecast
5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global Neuromodulation Devices Consumption and Value by Application
5.1.1 Global Neuromodulation Devices Consumption by Application 2016-2021
5.1.2 Global Neuromodulation Devices Market Value by Application 2016-2021
5.2 Global Neuromodulation Devices Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Chronic Pain Market Consumption, Value and Growth Rate
5.2.2 Parkinson's Disease Market Consumption, Value and Growth Rate
5.2.3 Urinary Fecal Incontinence Market Consumption, Value and Growth Rate
5.2.4 Refractory Epilepsy Market Consumption, Value and Growth Rate
5.2.5 Essential Tremor Market Consumption, Value and Growth Rate
5.2.6 Dystonia Market Consumption, Value and Growth Rate
5.2.7 Gastroparesis Market Consumption, Value and Growth Rate
5.2.8 Treatment-Resistant Depression (TRD) Market Consumption, Value and Growth Rate
5.2.9 Obsessive Compulsive Disorder (OCD) Market Consumption, Value and Growth Rate
5.2.10 Other Applications Market Consumption, Value and Growth Rate
5.3 Global Neuromodulation Devices Consumption and Value Forecast by Application
5.3.1 Global Neuromodulation Devices Consumption Forecast by Application 2022-2030
5.3.2 Global Neuromodulation Devices Market Value Forecast by Application 2022-2030
5.4 Global Neuromodulation Devices Market Consumption, Value and Growth Rate by Application Forecast 2022-2030
5.4.1 Chronic Pain Market Consumption, Value and Growth Rate Forecast
5.4.2 Parkinson's Disease Market Consumption, Value and Growth Rate Forecast
5.4.3 Urinary Fecal Incontinence Market Consumption, Value and Growth Rate Forecast
5.4.4 Refractory Epilepsy Market Consumption, Value and Growth Rate Forecast
5.4.5 Essential Tremor Market Consumption, Value and Growth Rate Forecast
5.4.6 Dystonia Market Consumption, Value and Growth Rate Forecast
5.4.7 Gastroparesis Market Consumption, Value and Growth Rate Forecast
5.4.8 Treatment-Resistant Depression (TRD) Market Consumption, Value and Growth Rate Forecast
5.4.9 Obsessive Compulsive Disorder (OCD) Market Consumption, Value and Growth Rate Forecast
5.4.10 Other Applications Market Consumption, Value and Growth Rate Forecast
6 Global Neuromodulation Devices by Region, Historical Data and Market Forecasts
6.1 Global Neuromodulation Devices Sales by Region 2016-2021
6.2 Global Neuromodulation Devices Market Value by Region 2016-2021
6.3 Global Neuromodulation Devices Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global Neuromodulation Devices Sales Forecast by Region 2022-2030
6.5 Global Neuromodulation Devices Market Value Forecast by Region 2022-2030
6.6 Global Neuromodulation Devices Market Sales, Value and Growth Rate Forecast by Region 2022-2030
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa
7 United State Market Size Analysis 2016-2030
7.1 United State Neuromodulation Devices Value and Market Growth 2016-2021
7.2 United State Neuromodulation Devices Sales and Market Growth 2016-2021
7.3 United State Neuromodulation Devices Market Value Forecast 2022-2030
8 Canada Market Size Analysis 2016-2030
8.1 Canada Neuromodulation Devices Value and Market Growth 2016-2021
8.2 Canada Neuromodulation Devices Sales and Market Growth 2016-2021
8.3 Canada Neuromodulation Devices Market Value Forecast 2022-2030
9 Germany Market Size Analysis 2016-2030
9.1 Germany Neuromodulation Devices Value and Market Growth 2016-2021
9.2 Germany Neuromodulation Devices Sales and Market Growth 2016-2021
9.3 Germany Neuromodulation Devices Market Value Forecast 2022-2030
10 UK Market Size Analysis 2016-2030
10.1 UK Neuromodulation Devices Value and Market Growth 2016-2021
10.2 UK Neuromodulation Devices Sales and Market Growth 2016-2021
10.3 UK Neuromodulation Devices Market Value Forecast 2022-2030
11 France Market Size Analysis 2016-2030
11.1 France Neuromodulation Devices Value and Market Growth 2016-2021
11.2 France Neuromodulation Devices Sales and Market Growth 2016-2021
11.3 France Neuromodulation Devices Market Value Forecast 2022-2030
12 Italy Market Size Analysis 2016-2030
12.1 Italy Neuromodulation Devices Value and Market Growth 2016-2021
12.2 Italy Neuromodulation Devices Sales and Market Growth 2016-2021
12.3 Italy Neuromodulation Devices Market Value Forecast 2022-2030
13 Spain Market Size Analysis 2016-2030
13.1 Spain Neuromodulation Devices Value and Market Growth 2016-2021
13.2 Spain Neuromodulation Devices Sales and Market Growth 2016-2021
13.3 Spain Neuromodulation Devices Market Value Forecast 2022-2030
14 Russia Market Size Analysis 2016-2030
14.1 Russia Neuromodulation Devices Value and Market Growth 2016-2021
14.2 Russia Neuromodulation Devices Sales and Market Growth 2016-2021
14.3 Russia Neuromodulation Devices Market Value Forecast 2022-2030
15 China Market Size Analysis 2016-2030
15.1 China Neuromodulation Devices Value and Market Growth 2016-2021
15.2 China Neuromodulation Devices Sales and Market Growth 2016-2021
15.3 China Neuromodulation Devices Market Value Forecast 2022-2030
16 Japan Market Size Analysis 2016-2030
16.1 Japan Neuromodulation Devices Value and Market Growth 2016-2021
16.2 Japan Neuromodulation Devices Sales and Market Growth 2016-2021
16.3 Japan Neuromodulation Devices Market Value Forecast 2022-2030
17 South Korea Market Size Analysis 2016-2030
17.1 South Korea Neuromodulation Devices Value and Market Growth 2016-2021
17.2 South Korea Neuromodulation Devices Sales and Market Growth 2016-2021
17.3 South Korea Neuromodulation Devices Market Value Forecast 2022-2030
18 Australia Market Size Analysis 2016-2030
18.1 Australia Neuromodulation Devices Value and Market Growth 2016-2021
18.2 Australia Neuromodulation Devices Sales and Market Growth 2016-2021
18.3 Australia Neuromodulation Devices Market Value Forecast 2022-2030
19 Thailand Market Size Analysis 2016-2030
19.1 Thailand Neuromodulation Devices Value and Market Growth 2016-2021
19.2 Thailand Neuromodulation Devices Sales and Market Growth 2016-2021
19.3 Thailand Neuromodulation Devices Market Value Forecast 2022-2030
20 Brazil Market Size Analysis 2016-2030
20.1 Brazil Neuromodulation Devices Value and Market Growth 2016-2021
20.2 Brazil Neuromodulation Devices Sales and Market Growth 2016-2021
20.3 Brazil Neuromodulation Devices Market Value Forecast 2022-2030
21 Argentina Market Size Analysis 2016-2030
21.1 Argentina Neuromodulation Devices Value and Market Growth 2016-2021
21.2 Argentina Neuromodulation Devices Sales and Market Growth 2016-2021
21.3 Argentina Neuromodulation Devices Market Value Forecast 2022-2030
22 Chile Market Size Analysis 2016-2030
22.1 Chile Neuromodulation Devices Value and Market Growth 2016-2021
22.2 Chile Neuromodulation Devices Sales and Market Growth 2016-2021
22.3 Chile Neuromodulation Devices Market Value Forecast 2022-2030
23 South Africa Market Size Analysis 2016-2030
23.1 South Africa Neuromodulation Devices Value and Market Growth 2016-2021
23.2 South Africa Neuromodulation Devices Sales and Market Growth 2016-2021
23.3 South Africa Neuromodulation Devices Market Value Forecast 2022-2030
24 Egypt Market Size Analysis 2016-2030
24.1 Egypt Neuromodulation Devices Value and Market Growth 2016-2021
24.2 Egypt Neuromodulation Devices Sales and Market Growth 2016-2021
24.3 Egypt Neuromodulation Devices Market Value Forecast 2022-2030
25 UAE Market Size Analysis 2016-2030
25.1 UAE Neuromodulation Devices Value and Market Growth 2016-2021
25.2 UAE Neuromodulation Devices Sales and Market Growth 2016-2021
25.3 UAE Neuromodulation Devices Market Value Forecast 2022-2030
26 Saudi Arabia Market Size Analysis 2016-2030
26.1 Saudi Arabia Neuromodulation Devices Value and Market Growth 2016-2021
26.2 Saudi Arabia Neuromodulation Devices Sales and Market Growth 2016-2021
26.3 Saudi Arabia Neuromodulation Devices Market Value Forecast 2022-2030
27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI